Celltrion Logo

Celltrion

🇰🇷
068270
KR7068270008

Celltrion, a leading South Korean biopharmaceutical company, develops and manufactures innovative biosimilars and novel drugs. The company focuses on research and development to provide patient-centric therapies for global healthcare needs. Utilizing cutting-edge biotechnology, Celltrion enhances access to high-quality pharmaceutical solutions worldwide.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 8, 2026

Stock Price

Recap: the latest results

Celltrion (068270) reported its Q3 2026 financial results on July 3, 2026, before market open. The company's earnings per share (EPS) came in at 1,351.86 KRW, which missed the analyst estimate of 1,450.51 KRW by 6.8%. Celltrion reported a revenue of 1,305,000 million KRW, and the stock price reacted with an increase of 3.96% after the release.

Generated automatically from our data — as of 07/12/2026 Read the article →

Frequently asked questions

When will Celltrion report its next quarterly earnings?

Celltrion is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Celltrion last report quarterly earnings?

Celltrion last reported quarterly earnings on 7/3/2026 (Q2 2026). Earnings per share (EPS) came in at 1,623.12 KRW.

How does Celltrion stock react to earnings?

Across its last 4 earnings reports, Celltrion stock moved by ±2% on average the following day. The largest reaction was +4% on 07/03/2026; 3 of 4 reactions were positive.

How often has Celltrion beaten expectations?

Celltrion has beaten analyst EPS estimates in 4 of its last 4 evaluated quarters (beat rate: 100%).

How do I add the Celltrion earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:₩1,622.68
Actual:
Q2 2026
Beat
Estimate:₩1,450.51
Actual:₩1,623.12
Difference:+₩172.61
Price reaction (1 day):+4.0 %
Price reaction (7 days):-0.8 %
Q1 2026
Beat
Estimate:₩1,146.89
Actual:₩1,501.06
Difference:+₩354.17
Price reaction (1 day):-1.6 %
Price reaction (7 days):-3.7 %
Q4 2025
Beat
Estimate:₩1,651.73
Actual:₩2,177.03
Difference:+₩525.30
Price reaction (1 day):+1.4 %
Price reaction (7 days):+11.2 %
Q3 2025
Beat
Estimate:$1,070.53
Actual:$1,436.19
Difference:+$365.66
Price reaction (1 day):+1.2 %
Price reaction (7 days):+1.9 %

Earnings statistics

Stock reaction to earnings

±2%
Avg. next-day move
+4%
Largest move (07/03/2026)
75%
Share of positive reactions
±4.4%
Avg. move after 7 days

Basis: price reactions to the last 4 report dates (close to close).

Estimates vs. results

4/4
Quarters above estimates
100%
Beat rate
+18.7%
Avg. EPS surprise

Basis: 4 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Celltrion
Ticker Symbol
068270
ISIN
KR7068270008
Country
🇰🇷
Korea, Republic of
Sector
More Financial Information